pre-eclampsia
Conditions
Interventions
placebo:Observation of pregnancy outcomes in pregnant women and clinical outcomes in newborns after regular placebo administration during pregnancy
treatment group:Observation of pregnancy outcomes in pregnant women and clinical outcomes in newborns after regular use of probiotics (pefilgrastim) during pregnancy
Sponsors
Ningbo Women and Children’s Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) Age: Female patients aged 18-45 years; (2) Pregnant women with clinically confirmed pre-eclampsia; (3) Single pregnancy; (4) Subjects voluntarily enrolled in the study, signed an informed consent form, complied well, and cooperated with follow-up visits.
Exclusion criteria
Exclusion criteria: (1) Twin pregnancies; (2) Combined diabetes; (3) Suffering from severe pregnancy complications and co-morbidities; (4) Fetal malformations, etc. (5) Those deemed unsuitable for inclusion by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weeks of gestation of pregnant women in labour;Neonatal birth outcomes; | — |
Secondary
| Measure | Time frame |
|---|---|
| outcomes for pregnant women;Liver function, renal function; | — |
Countries
China
Contacts
Public ContactAner Chen
Ningbo Women and Children’s Hospital
Outcome results
None listed